Introduction {#s1}
============

Type 2 diabetes mellitus (T2DM) affects 415 million individuals and is predicted to increase to 642 million in 2040, according to the Diabetes Atlas 7th Edition published by the International Diabetes Federation (<http://www.idf.org/about-diabetes/facts-figures>). Numerous studies have suggested that T2DM is closely associated with cognitive impairment, including the domains of motor function, executive function, processing speed and memory (Palta et al., [@B35]). Clarification of the underlying mechanism of cognitive impairment in T2DM patients for diagnosis and therapeutic effect estimation is essential before these patients develop dementia.

As a proven informative neuroimaging method, functional magnetic resonance imaging (fMRI) has been extensively applied to investigate alterations of brain function in T2DM patients. In fMRI studies, T2DM patients manifest functional changes in certain brain regions, and these changes are different from those associated with normal aging. For instance, the abnormal amplitude of low-frequency fluctuation, regional homogeneity, and functional connectivity (FC) in T2DM patients have been associated with poor performance in cognitive tests (Xia et al., [@B49]; Chen et al., [@B10]; Cui et al., [@B15], [@B14]; Moheet et al., [@B33]). These studies have focused on local spontaneous brain activity or have analyzed the FC or network within the selected brain regions based on a priori assumption. According to the graph theory, a network is defined as a set of pairwise relationships between the elements of a system, which formally consists of a set of edges that link a set of nodes (Barabasi and Oltvai, [@B3]; Petersen and Sporns, [@B39]). Network analysis offers a new conceptual framework to investigate the network biology of aging (Wolfson et al., [@B48]; Tacutu et al., [@B44]), T2DM (Sandor et al., [@B41]) and neurodegenerative diseases (de Haan et al., [@B18]) at a variety of levels of scale including genes, proteins, synapses, neurons, neuronal circuits, neuronal populations, and systems (Petersen and Sporns, [@B39]). Therefore, the aforementioned fMRI findings provide a clue to explore T2DM-related brain dysfunction from the perspective of macroscopic nodes and connectivity at the whole brain level, which may share universal laws of network.

Degree centrality (DC), a measure based on graph theory, provides an approach for identifying the candidate functional hubs in the diabetic brain. DC is defined as the number of links that are strongly correlated to a given voxel or node for a binary graph and enables whole brain analysis at the voxel level, which may avoid the bias caused by selecting brain regions according to a priori assumption (Buckner et al., [@B8]; Zuo et al., [@B54]). It also considers the weights of these links for a weighted graph, and the weighted version of DC is more robust against confounding factors (Zuo et al., [@B54]). Thus, it can quantify the importance of a node to the rest of the brain, and nodes with high DC are defined as hubs (Zuo et al., [@B54]). Therefore, DC enables an investigation of the complexity and patterns of the brain functional connectome in diseases, including the subsequent analysis of FC between the hubs and the rest of the brain (Cui et al., [@B16]), or the interactions among these functional hubs in the present study.

Connectivity depicts the relationships among functionally segregated brain systems and can be classified into undirected and directed functional connectivity. Traditional FC is often used to investigate the statistical dependencies among several given seed regions in an undirected manner (Biswal et al., [@B6]). Directed FC is explicitly used to explore the functional interactions in a directed manner and can be estimated using the Granger causality model (Seth et al., [@B42]). The positive casual effect and negative causal effect can be quantified with positive and negative signed-path coefficients and interpreted as activation and inhibition, respectively (Hamilton et al., [@B24]). Both undirected and directed FC are the components of functional integration that are used to analyze functional brain architectures (Friston et al., [@B20]). By combining the traditional FC and Granger causality analysis (GCA) approaches, more information can be obtained from different perspectives to map the connectivity pattern among the brain functional hubs that are probably affected by T2DM.

In this study, we hypothesized that the aberrant brain function of hubs and their connectivity may contribute to brain dysfunction in T2DM patients. The DC method was applied to identify the candidate functional hubs. Next, the FC and GCA methods were applied to investigate the connectivity among these functional hubs. We also investigated the relationships of brain functional alterations with clinical data and neuropsychological performance. Our study provides evidence to further understand the neurological mechanisms that underlie T2DM-associated cognitive impairment.

Materials and methods {#s2}
=====================

Subjects
--------

T2DM patients were recruited from inpatients and the community and healthy controls (HC) were recruited from the community between December 2013 and December 2015. Forty-seven T2DM patients and 47 healthy controls, who were matched with regard to age, sex, education and body mass index (BMI), were enrolled in the study. Both the T2DM patients and the healthy controls met the following inclusion criteria: (1) between 45 and 70 years old; 2) at least six years of education; and (3) right-handedness. T2DM was diagnosed by endocrinologists according to the criteria published by the World Health Organization in 1999 (Alberti and Zimmet, [@B1]). The T2DM patients had at least 1 year of disease duration. The exclusion criteria for all participants were as follows: (1) organic disease in the brain, such as stroke, tumor, or a white matter lesion rating score ≥ 2 (Wahlund et al., [@B46]); (2) physical disability; (3) pregnancy, thyroid dysfunction; (4) signs of dementia (Mini-Mental State Examination \[MMSE\] score ≤ 24) (Galea and Woodward, [@B21]), major depression (Hamilton Depression Rating Scale-24 item \[HAMD\] \> 20) (Hamilton, [@B25]), or other psychiatric disorders; (5) severe hearing or visual impairment; and (6) contraindications to MRI. Patients with T2DM-related complications were also excluded, including diabetic foot, retinopathy, and nephropathy.

The study protocol was approved by the Medical Research Ethics Committee of the Southwest Hospital (Chongqing, China). Written informed consent was obtained from participants after they were informed of the study details. Additionally, the study process strictly obeyed the protocol.

Clinical data
-------------

The following information about the subjects was recorded using a standardized protocol: handedness, height, weight, BMI \[weight in kg\]/\[height in m\]^2^), resting arm arterial blood pressure, medical history and current medications. For T2DM patients, we also recorded the date of diagnosis to calculate the disease duration. Venous blood samples were collected by venipuncture after overnight fasting for the biometric measurements, including glucose-related parameters (fasting plasma glucose, fasting insulin, fasting C-peptide, and glycosylated hemoglobin \[HbA~1c~\]), lipoid parameters (total cholesterol, triglyceride, high-density lipoprotein \[HDL\] cholesterol, low-density lipoprotein \[LDL\] cholesterol), renal function parameters (blood urea nitrogen, serum creatine, uric acid, and cystatin C), thyroid function parameters (free triiodothyronine \[FT3\], free thyroxine \[FT4\] and thyroid-stimulating hormone \[TSH\]), and homocysteine. The updated homeostasis model assessment of the insulin resistance (HOMA2-IR) index was calculated using the HOMA2 Calculator v2.2.3 software (<http://www.dtu.ox.ac.uk/homacalculator/>) to evaluate insulin resistance in all subjects.

Neuropsychological tests
------------------------

All participants underwent cognitive status assessments with a battery of neuropsychological tests in a fixed order that assessed their global cognitive level and major cognitive subdomains. The global level of cognition was evaluated with the MMSE and Montreal Cognitive Assessment (MoCA) tests. The depressive state was evaluated with HAMD to exclude cases with major depression. The major cognitive subdomains were evaluated with the following tests: (1) the Trail Making Test (TMT, parts A and B) for executive function and psychomotor speed (Bowie and Harvey, [@B7]); (2) the Verbal Fluency Test (VFT) for mental flexibility (Diamond, [@B19]); (3) the Digit Span Test (DST, forwards and backwards) for working memory (Diamond, [@B19]); and (4) the Auditory Verbal Learning Test (AVLT, including immediate recall, short-term delayed recall, long-term delayed recall, long-term delayed recognition and total score) for episodic memory (Zhao et al., [@B53]). A trained neuropsychologist administered the battery of tests and was blinded to the group status. Each participant completed the assessment in approximately 60 min.

MRI data acquisition
--------------------

MRI scan was performed on the same day that the clinical data were obtained and the cognitive test was performed. MRI data were acquired using a 3.0-T MR scanner (Trio, Siemens Medical, Erlangen, Germany) and a 12-channel head coil. Subjects were instructed to close their eyes, stay awake and avoid thinking about any topics. Earplugs and cushions were used to alleviate noise influence and restrict head motion, respectively. T2-weighted images: repetition time = 6,000 ms, echo time = 89 ms, flip angle = 120°, field of view = 230 × 230 mm^2^, slices = 20, thickness = 5.0 mm, matrix = 448 × 448 and voxel size = 0.5 × 0.5 × 5.0 mm^3^. Fluid-attenuated inversion recovery (FLAIR) images: repetition time = 9,000 ms, echo time = 93 ms, flip angle = 130°, field of view = 220 × 220 mm^2^, slices = 25, thickness = 4.0 mm, matrix = 256 × 256 and voxel size = 0.9 × 0.9 × 4.0 mm^3^. Resting-state functional images were collected using an echo planar imaging (EPI) sequence: repetition time = 2,000 ms, echo time = 30 ms, flip angle = 90°, field of view = 192 × 192 mm^2^, slices = 36, thickness = 3 mm, matrix = 64 × 64 and voxel size = 3 × 3 × 3 mm^3^; 240 volumes were transversely acquired. T1-weighted structural images were collected using a volumetric 3D magnetization prepared by rapid-acquisition gradient-echo (MP-RAGE) sequence: repetition time = 1,900 ms, echo time = 2.52 ms, flip angle = 9°, field of view = 256 × 256 mm^2^, slices = 176, thickness = 1 mm, matrix = 256 × 256 and voxel size = 1 × 1 × 1 mm^3^, sagittally scanned.

MRI data analysis
-----------------

No subjects were excluded after the T2-weighted and FLAIR images were reviewed by two radiologists with at least five years of work experience.

Structural and functional data analyses were performed using toolkits based on Statistical Parametric Mapping 8 software (SPM 8, <http://www.fil.ion.ucl.ac.uk/spm>). Intracranial tissue segmentation was performed with Voxel Based Morphometry Toolbox 8 software (VBM8, version 435) according to a previously described protocol (Whitwell, [@B47]). The main steps include spatial normalization to match every subject\'s T1-weighed images to the template image, and segmentation of the intracranial tissue into gray matter, white matter and cerebrospinal fluid, which automatically produces information about the volumes of each part of the brain tissue. Gray matter was smoothed with 4 mm full-width half-maximum.

Functional data were preprocessed using Data Processing Assistant for Resting-State fMRI (DPARSF module v4.1 of Data Processing & Analysis of Brain Imaging v2.1, <http://rfmri.org/dpabi>) according to the standard procedure (Yan and Zang, [@B51]). All DICOM files were converted to NifTI files. Next, the first 10 volumes were removed to enable the subjects to adapt to the scanning environment, especially the noise. Slice-timing was performed to correct the time differences between slices. Realignment was performed to correct head motion, and a report of head motion was created. Any subjects with head motion \> 2.0 mm in any direction of x, y, and x or \> 2.0° at any angle were excluded from the subsequent statistical analyses. Friston 24-parameter model was applied to regress out head motion effects (Yan et al., [@B50]). Other nuisance variables including white matter signal and cerebrospinal fluid signal were regressed out. Individual functional images were normalized into the Montreal Neurological Institute (MNI) space for intersubject comparison. The resulting images were smoothed with 4 mm full-width half-maximum. Detrending was applied to remove the systematic drift of the baseline signal. The data were bandpass filtered (0.01--0.08 Hz) to reduce physiological noise at other bands of frequency.

Based on preprocessing, DC calculations were performed using DPARSF in a voxel-wise manner with a threshold *r* \> 0.25 in accordance with previous studies (Beucke et al., [@B5]; Mueller et al., [@B34]). Peak MNI coordinates of the candidate brain functional hubs were obtained via group comparison of DC maps and considered to be the center of the spherical region of interest (ROI) with a 6-mm radius. Connectivity among the ROIs was analyzed using rs-fMRI data analysis toolkits (REST v1.8, <http://www.restfmri.net>) in a ROI-wise manner, including FC and GCA analyses. For FC, the correlation coefficients between the ROIs were computed and normalized with Fisher\'s *r*-to-*z* transformation. For GCA, signed-path coefficients between ROIs were computed in a multivariate mode for the subsequent parametric statistical analyses (Hamilton et al., [@B24]).

Statistical analysis
--------------------

Inter-group comparisons of numeric data were conducted using SPSS software (version 20.0; IBM Corp., Armonk, NY) and included demographic data, clinical parameters, and neuropsychological test scores. First, the data distribution was verified using the Kolmogorov-Smirnov test. Second, independent samples of the *t*-test and Mann-Whitney U test were applied to normally distributed continuous data and to non-normally distributed data, respectively. The sex proportion was examined with the χ^2^ test. *p* \< 0.05 indicated statistical significance.

Intra- and inter-group analyses of DC maps were conducted using REST software. A one-sample *t*-test was applied to investigate the DC pattern with the base of "0" in the intra-group. An independent *t*-test was applied to investigate the DC differences between the groups with age, sex, education, BMI, blood pressure, blood biometric parameters (except fasting glucose, fasting insulin, fasting C-peptide and HbA~1c~) entered as covariates. Gray matter maps were also included as covariates to control the influence of structural changes in the T2DM patients. The resulting maps were corrected for multiple comparisons using AlphaSim (*p* \< 0.001, cluster size \> 20 voxels, number of Monte Carlo simulations = 10,000, cluster connection radius: rmm = 5.0).

For the z scores of FC and signed-path coefficients, statistical analyses were performed using SPSS software. A one-sample *t*-test was applied to investigate the patterns of FC and GCA in each group. An independent sample *t*-test was applied to investigate the differences between T2DM patients and healthy controls in terms of FC and GCA. The relationships of DC and connectivity with clinical parameters and neuropsychological test scores were explored through partial correlation analyses in SPSS software within the T2DM group. Both the independent sample *t*-test and the correlation analysis were adjusted with gray matter volumes, and the same covariates that employed in the inter-group analyses of the DC maps were applied to control their possible effect on the results. The independent sample *t*-test was also controlled for multiple comparisons with Bonferroni correction (*p* \< 0.05/6 for FC and *p* \< 0.05/12 for GCA).

Results {#s3}
=======

Demographic and clinical data comparison
----------------------------------------

No significant inter-group differences were found in terms of age, sex, education, BMI, blood pressure, total cholesterol, LDL cholesterol, blood urea nitrogen, cystatin C, uric acid and TSH. The T2DM patients had significantly higher levels of glucose-related parameters, including fasting plasma glucose, fasting insulin, HbA~1c~ and HOMA2-IR index (all *p* \< 0.05). The T2DM patients had significantly higher levels of triglycerides and homocysteine but lower fasting C-peptide and serum creatine levels (all *p* \< 0.05). The inter-group differences in FT3 and FT4 were significant (all *p* \< 0.05); however, the levels were within the normal range. The details are presented in Table [1](#T1){ref-type="table"}.

###### 

Demographic and clinical data of the subjects.

                                             **T2DM**               **HC**                 ***p-*value**
  ------------------------------------------ ---------------------- ---------------------- ---------------------------------------
  Age (years)                                58.66 ± 6.87           57.36 ± 5.42           0.312
  Sex (male:female)                          28/19                  25/22                  0.533[^a^](#TN1){ref-type="table-fn"}
  Education (years)                          10.60 ± 3.06           10.77 ± 2.65           0.773
  T2DM duration (years)                      8.87 ± 6.61            --                     --
  BMI (kg/m^2^)                              25.46 ± 5.11           23.94 ± 3.87           0.109
  Gray matter (cm^3^)                        608.15 ± 58.00         615.16 ± 51.67         0.538
  White matter (cm^3^)                       534.91 ± 64.85         524.16 ± 66.56         0.430
  Brain parenchyma (cm^3^)                   1143.06 ± 114.78       1139.32 ± 107.80       0.871
  Systolic blood pressure (mmHg)             128.91 ± 16.81         134.55 ± 17.88         0.119
  Diastolic blood pressure (mmHg)            79.49 ± 10.01          80.26 ± 10.25          0.715
  HbA~1c~ (%)                                8.26 ± 2.08            5.63 ± 0.39            \<0.001
  HbA~1c~ (mmol/mol)                         66.76 ± 22.80          38.15 ± 4.33           \<0.001
  Fasting plasma glucose (mmol/L)            7.47 ± 2.70            5.22 ± 0.46            \<0.001
  Fasting insulin (mIU/L)                    14.91 (9.58, 24.54)    11.41 (8.39, 17.10)    0.035[^b^](#TN2){ref-type="table-fn"}
  Fasting C-peptide (ng/mL)                  1.81 ± 1.05            2.22 ± 0.90            0.047
  HOMA2-IR                                   0.28 (0.19, 0.52)      0.21 (0.16, 0.32)      0.015[^b^](#TN2){ref-type="table-fn"}
  Total cholesterol (mmol/L)                 4.89 ± 1.04            5.10 ± 1.02            0.325
  Triglyceride (mmol/L)                      1.45 (1.05, 1.98)      1.23 (0.91, 1.48)      0.023[^b^](#TN2){ref-type="table-fn"}
  HDL cholesterol (mmol/L)                   1.06 ± 0.23            1.41 ± 0.36            \<0.001
  LDL cholesterol (mmol/L)                   3.16 ± 0.83            3.27 ± 0.76            0.489
  Homocysteine (μmol/L)                      16.62 ± 10.03          10.70 ± 4.10           \<0.001
  Blood urea nitrogen (mmol/L)               6.36 ± 2.45            5.72 ± 1.23            0.113
  Serum creatine (μmol/L)                    65.00 (57.00, 78.00)   78.00 (66.00, 85.00)   0.007[^b^](#TN2){ref-type="table-fn"}
  Cystatin C (mg/L)                          0.72 (0.64, 0.91)      0.76 (0.69, 0.86)      0.639[^b^](#TN2){ref-type="table-fn"}
  Uric acid (μmol/L)                         316.67 ± 79.72         328.34 ± 69.09         0.450
  Free triiodothyronine, FT3 (pmol/L)        4.31 ± 0.91            5.13 ± 0.72            \<0.001
  Free thyroxine, FT4 (pmol/L)               15.52 ± 2.34           16.48 ± 1.89           0.032
  Thyroid-stimulating hormone, TSH (mIU/L)   2.12 ± 0.95            2.57 ± 1.54            0.090

*p \< 0.05 indicates statistical significance*.

*χ^2^ test for sex (n)*.

*Mann-Whitney U-test for non-normally distributed data \[median (QR)\]. Independent t-test for the other normally distributed continuous data (means ± SD). T2DM, type 2 diabetes mellitus; HC, healthy control; BMI, body mass index; HDL, high-density lipoprotein; LDL, low-density lipoprotein*.

Neuropsychological test comparison
----------------------------------

The T2DM patients exhibited poorer performance on the tests of MoCA, TMT-B, DST forwards and long-term delayed recall of AVLT (all *p* \< 0.05). No significant inter-group differences were observed in the other tests. The details are presented in Table [2](#T2){ref-type="table"}.

###### 

Comparison of the neuropsychological test results between the two groups.

                                                 **T2DM**               **HC**                 ***p*-value**
  ---------------------------------------------- ---------------------- ---------------------- ---------------------------------------
  **GENERAL COGNITION**                                                                        
  MMSE                                           29.00 (27.00, 29.00)   29.00 (28.00, 29.00)   0.203[^a^](#TN3){ref-type="table-fn"}
  MoCA                                           23.17 ± 2.88           24.51 ± 2.31           0.015
  **EXECUTIVE FUNCTION AND PSYCHOMOTOR SPEED**                                                 
  TMT-A                                          74.67 ± 41.11          64.17 ± 32.59          0.173
  TMT-B                                          183.19 ± 89.90         142.00 ± 58.35         0.010
  **MENTAL FLEXIBILITY**                                                                       
  VFT                                            42.17 ± 7.33           40.55 ± 7.05           0.279
  **WORKING MEMORY**                                                                           
  DST forwards                                   8.83 ± 1.37            9.60 ± 1.50            0.011
  DST backwards                                  4.00 (3.00, 5.00)      4.00 (3.00, 4.00)      0.911[^a^](#TN3){ref-type="table-fn"}
  **EPISODIC MEMORY**                                                                          
  AVLT immediate recall                          6.46 ± 1.69            6.86 ± 1.49            0.226
  AVLT short-term delayed recall                 6.77 ± 3.18            7.74 ± 2.41            0.096
  AVLT long-term delayed recall                  5.40 ± 3.77            6.72 ± 2.43            0.047
  AVLT long-term delayed recognition             11.00 (8.00, 13.00)    12.00 (9.00, 13.00)    0.327[^a^](#TN3){ref-type="table-fn"}
  AVLT total score                               28.97 ± 9.94           32.34 ± 7.45           0.065

*p \< 0.05 was considered statistically significant*.

*Mann-Whitney U-test for non-normally distributed data \[median (QR)\]. Independent t-test for the other normally distributed continuous data (means ± SD). MMSE, Mini-Mental State Examination; MoCA, Montreal Cognitive Assessment; TMT, Trail Making Test; VFT, Verbal Fluency Test; DST, Digital Span Test; AVLT, Auditory Verbal Learning Test*.

Brain volume comparison
-----------------------

The general volumes of gray matter, white matter and brain parenchyma (the sum of gray and white matter) revealed no significant differences between the two groups (Table [1](#T1){ref-type="table"}).

DC analysis
-----------

Compared to the global mean value, both groups displayed higher DC values in the posterior cingulate cortex, cuneus, angular gyrus, occipital cortex, superior frontal cortex, precentral gyrus and postcentral gyrus (Figures [1A,B](#F1){ref-type="fig"}). In the T2DM patients, significantly higher DC values were observed in the left anterior cingulate gyrus (ACG), and significantly lower DC values were observed in the bilateral lateral occipital cortices (LOC) and right precentral gyrus (PreCG). Details of the changed brain areas are presented in Table [3](#T3){ref-type="table"} (Figures [1C,D](#F1){ref-type="fig"}).

![DC value distribution of intra-group and inter-group comparisons. **(A,B)** The spatial distribution of the DC value in the HC group and T2DM group. **(C)** The significantly altered DC map in the T2DM group. **(D)** Comparison of DC value between the two groups. AlphaSim corrected (*p* \< 0.001, cluster size \> 20 voxels). The color bar denotes the *t*-value. Error bars define the SEM. ACG, anterior cingulate gyrus; LOC, lateral occipital cortices; PreCG, precentral gyrus; R, right; L, left.](fnagi-10-00055-g0001){#F1}

###### 

Brain regions with significant DC differences between the two groups.

      **Brain regions**                **BA**   **Peak MNI**   ***t*-value**   **Cluster (voxels)**             
  --- -------------------------------- -------- -------------- --------------- ---------------------- --------- -----
  1   Left anterior cingulate gyrus    32       −9             42              9                      3.1455    28
  2   Right lateral occipital cortex   19       27             −78             24                     −3.1327   20
  3   Left lateral occipital cortex    19       −24            −84             21                     −3.9907   147
  4   Right precentral gyrus           43       63             −3              30                     −3.4576   55

*MNI, Montreal Neurological Institute; BA, Broadmann Area. R, Right; L, left; AlphaSim corrected (p \< 0.001, cluster \> 20 voxels)*.

Connectivity analysis
---------------------

For the FC analyses, the one-sample *t*-test suggested that FC existed in both groups among the ROIs, including the left ACG, right PreCG, and bilateral LOC (all *p* \< 0.05; Figures [2A,B](#F2){ref-type="fig"}). The independent *t*-test suggested that the FC of the left ACG-right PreCG (*p* = 0.015) in T2DM patients was significantly stronger than that in the healthy controls, and the FC values of the left LOC-right PreCG (*p* = 0.011), right LOC-right PreCG (*p* = 0.019), and left LOC-right LOC (*p* = 0.001) were significantly weaker than those in the healthy controls (Figures [2C,D](#F2){ref-type="fig"}). After multiple comparisons correction, the FC of the left LOC-right LOC in T2DM patients was significantly weaker than that in the healthy controls (*p* \< 0.05/6).

![FC pattern of intra-group and inter-group comparisons. **(A,B**) The FC pattern in the HC group and T2DM group. **(C)** The significantly altered FC in the T2DM group. **(D)** Comparison of FC z scores between the two groups. ^\*^*p* \< 0.05, ^\#^*p* \< 0.05/6 (Bonferroni correction). Error bars define the SEM. ACG, anterior cingulate gyrus; LOC, lateral occipital cortices; PreCG, precentral gyrus; R, right; L, left.](fnagi-10-00055-g0002){#F2}

With respect to the GCA analyses, the one-sample *t*-test showed a positive causal effect from the left ACG to the left LOC and a negative causal effect from the left ACG to the right LOC in the healthy controls (Figures [3A,C](#F3){ref-type="fig"}). However, the conditions were inverted such that a negative causal effect from the left ACG to the left LOC and a positive causal effect from the left ACG to the right LOC were observed in the T2DM patients (Figures [3B,C](#F3){ref-type="fig"}). Significant differences between the two groups in terms of the two directed functional edges were observed (*p* \< 0.05; Figure [3C](#F3){ref-type="fig"}). Unfortunately, the independent *t*-test results of GCA could not bear the multiple comparisons correction (*p* \> 0.05/12).

![GCA pattern of intra-group and inter-group comparisons. **(A,B)** Causal effect patterns of the HC group and T2DM group. The red arrow indicates a positive casual effect and its direction. The blue arrow indicates a negative casual effect and its direction. **(C)** Comparison of signed-path coefficients between the two groups. ^\*^*p* \< 0.05. Error bars define the SEM.](fnagi-10-00055-g0003){#F3}

Correlation analysis
--------------------

Signed-path coefficients from the left ACG to the left LOC were negatively correlated with fasting C-peptide levels (ρ = −0.386, *p* = 0.007; Figure [4A](#F4){ref-type="fig"}) in T2DM patients. Poor performance on the DST forwards was associated with elevated HbA~1c~ levels in T2DM patients (HbA~1c~ \[%\], ρ = −0.301, *p* = 0.040; HbA~1c~ \[mmol/mol\], ρ = −0.301, *p* = 0.040; Figure [4B](#F4){ref-type="fig"}). However, no correlations were observed between disrupted DC or connectivity and lower scores on the neuropsychological tests or disease duration.

![Correlations among the connectivity, neuropsychological performance and diabetes-related parameters. **(A)** Signed-path coefficients of the left ACG to the left LOC vs. C-peptide (ng/mL). **(B)** DST forwards vs. HbA~1c~(%).](fnagi-10-00055-g0004){#F4}

Discussion {#s4}
==========

To explore the possible neurological mechanisms underlying cognitive dysfunction in T2DM patients, we combined the DC, FC and GCA approaches to investigate the changes in the candidate brain functional hubs and their connectivity. The increased DC in left ACG and decreased DC in the occipital areas were consistent with a previous study (Cui et al., [@B16]). A novel finding was the increased DC in the right PreCG. The changed FC pattern of right PreCG may be associated with impaired preparation and execution of goal-directed actions. The GCA approach further revealed the disordered direct connectivity from the left ACG to bilateral occipital areas.

The brain regions where identified hubs are located have been reported to be abnormal in previous studies using other neuroimaging metrics in T2DM patients, which suggests that these brain regions are susceptible to T2DM. The ACG is usually identified as the disturbed brain region across experiments and appeared with increased amplitude of low-frequency fluctuation, regional homogeneity (Cui et al., [@B15]; Liu D. et al., [@B29]), and cerebral blood flow (Cui et al., [@B17]). The aforementioned hyperactivity of ACG has usually been regarded as a means to compensate for the cognitive loss and maintain normal cognition (He et al., [@B26]; Liu D. et al., [@B29]; Cui et al., [@B17]). However, the mechanism of the compensation requires further research. In contrast, a decreased amplitude of low-frequency fluctuation and regional homogeneity were observed in the occipital lobe (Xia et al., [@B49]; Cui et al., [@B15]; Peng et al., [@B37]). Decreased connectivity of the PreCG was found with the posterior cingulate cortex (Chen et al., [@B10]) and the thalamic (Chen et al., [@B11]). These brain regions also exhibited gray matter atrophy in T2DM patients (Chen et al., [@B12]; Garcia-Casares et al., [@B22]; Peng et al., [@B36]). We discovered a change in the number of edges that connect the bilateral LOC and right PreCG, which rendered these brain regions candidate functional hubs to be damaged in T2DM patients (Zuo et al., [@B54]). These findings provided information about the reorganized layout of the brain network with a graph theory-based approach in addition to previous studies.

Placing the identified brain functional hubs into the context of brain local networks, the changed FC of the right PreCG may suggest impaired preparation and execution of goal-directed actions. The motor system participates in the constitution of internal representations of sensory information (Crowe et al., [@B13]) and obtains visually perceived information to prepare a motor response (Merchant and Georgopoulos, [@B32]). However, the decreased DC and FC values of the right PreCG indicated its decline in communication efficiency with the visual cortex and other brain regions. Additionally, the motor system is closely connected with the ACG which mediates focusing attention on targets to select appropriate actions (Isomura et al., [@B27]). The increased FC between the ACG and PreCG may be interpreted as brain efforts to guide motor behavior. Notably, the process of goal-directed action is a main constituent of executive function. Moreover, for its motor speed component, the poor executive performance in TMT-B may be the behavioral level evidence of cognitive and motor system dysfunction.

The GCA results may further suggest that the reorganization of the brain network in T2DM patients may be associated with the impaired visual information acquisition for executive function. The ACG serves an important role in the top-down control network (Petersen and Posner, [@B38]). The occipital cortex is an important brain area of vision-related information encoding for working memory which is the primary component of executive function (Bentley et al., [@B4]; Diamond, [@B19]). Furthermore, visual cortex can be mediated by the ACG which monitors and resolves conflict by enhancing the to-be-attended information and suppressing distracter stimuli (Petersen and Posner, [@B38]; Liu Y. et al., [@B30]). In this study, the disordered excitatory and inhibitory effects from the ACG to the visual cortex suggest that T2DM patients may experience a cognitive impairment in visual information acquisition that is indirectly related to the deficit in executive function. In addition, unlike the scale free organization of molecular networks (Budovsky et al., [@B9]; Tacutu et al., [@B43]), the human brain network was proposed to exhibit prominent small-world architecture which facilitates efficient information communication (Liao et al., [@B28]). The impacts of brain functional hubs and connectivity alterations on the small-world property remains to be further explored.

GCA connections appear at where FC connections exist; however, we observed that there was no overlap of significant alterations between undirected and directed connectivity in the present study. On one hand, undirected FC is usually assessed with the correlation coefficient, which can be regarded as descriptive (Biswal et al., [@B6]). On the other hand, the directed FC depicted by GCA rests explicitly on the linear vector autoregressive models (Seth et al., [@B42]). It is difficult to make a direct comparison between correlation data and a model. The non-overlapping alterations between the undirected and directed connectivity may result from the distinction of mathematical theories. It is also reported that internet gaming disorder individuals without FC alterations exhibited impaired GCA connections (Guller et al., [@B23]). This phenomenon requires a further investigation.

Our finding also suggested that the level of glycemic parameters may be linked to the reserve of normal brain function in T2DM patients. Elevated HbA~1c~ was negatively correlated with spontaneous brain activity in the middle temporal gyrus (Xia et al., [@B49]) and with cognitive performance such as VFT (Chen et al., [@B10]). The higher insulin resistance has been associated with decreased FC between the posterior cingulate cortex and middle temporal gyrus (Chen et al., [@B10]; Yang et al., [@B52]). With the higher elevation of C-peptide in this study, a greater deviation of directed FC was observed in patients than in the healthy controls. Additionally, the patients with lower HbA~1c~ levels obtained higher scores on the DST forwards. The results were similar to those of several previous studies, which indicated that T2DM patients with elevated glycemic parameters exhibited decreased/inverted brain functional activity and poor cognitive performance (Xia et al., [@B49]; Chen et al., [@B10]; Liu D. et al., [@B29]; Yang et al., [@B52]). However, the findings of this study did not provide sufficient information about the relationships between the altered brain function and cognitive performance. Additional studies are required to investigate these mysteries.

The main limitations of the present investigation are as follows: First, the study comprised a relatively small population. The inter-group comparisons of FC and GCA were unable to bear the multiple corrections. These factors may restrict its statistical power and the explanation of the results. Second, we deduced the visually related cognition impairment in T2DM patients according to fMRI metrics. However, the lack of assessment on this cognitive domain weakened the basis of our inference. Third, the approach of GCA is controversial due to the poor temporal resolution in fMRI studies. However, the GCA method remains a powerful tool to explore the directed connectivity and helps elucidate the complexity of the brain (Seth et al., [@B42]). A large-sample study with comprehensive cognitive assessments and the application of new technology, such as compressed sensing (Lustig et al., [@B31]), to accelerate the sampling may solve these problems in the future. We are also considering the application of other network measurements, for instance, betweenness, closeness, path length (Rubinov and Sporns, [@B40]), which could be combined with the molecular networks to map the complex biological systems of T2DM-related cognitive impairment in depth (Barabasi et al., [@B2]; Vidal et al., [@B45]).

Conclusions {#s5}
===========

Our findings suggest that the DC of the left ACG, bilateral LOC and right PreCG, as well as the connectivity among them reflected by FC and GCA in different perspectives, are altered in T2DM patients. These alterations may be associated with the disruption of visual information acquisition and goal-directed action execution, both of which have previously proven to be related to executive function. Patients with lower glycemic parameters may reserve more normal brain functions. This study provides insight into the neurological underpinnings of T2DM-related cognitive impairment using neuroimaging.

Author contributions {#s6}
====================

DL contributed to the experiments, data analysis and writing of the manuscript. SD contributed to performing the experiments and writing and revising the manuscript. CZ contributed to the data collection. PW designed the experiment and revised the manuscript. LC contributed to the data analysis and manuscript revision. XY contributed to the manuscript revision. JZ and JW are the guarantors of this study and had complete access to all data in the study. They accept responsibility for the integrity of the data and the accuracy of the data analysis.

Conflict of interest statement
------------------------------

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

The authors thank all volunteers who participated in the study and the staff of the Department of Laboratory Medicine and Department of Nuclear Medicine at the Southwest Hospital of the Third Military Medical University (Army Medical University) in Chongqing, China for their selfless and valuable assistance.

**Funding.** The study was supported by the National Natural Science Foundation of China (81471647, 81771814) and the Innovation Fund for Younger Investigators of Southwest Hospital of the Third Military Medical University (SWH2013QN09).

ACG

:   anterior cingulate gyrus

AVLT

:   Auditory Verbal Learning Test

BMI

:   body mass index

DC

:   degree centrality

DST

:   Digit Span Test

EPI

:   echo planar imaging

FC

:   functional connectivity

FLAIR

:   fluid-attenuated inversion recovery

fMRI

:   functional magnetic resonance imaging

FT3

:   free triiodothyronine

FT4

:   free thyroxine

GCA

:   Granger causality analysis

HAMD

:   Hamilton Depression Rating Scale

HbA~1c~

:   glycosylated hemoglobin

HC

:   healthy control

HDL

:   high-density lipoprotein

HOMA2-IR

:   updated homeostasis model assessment of insulin resistance

LDL

:   low-density lipoprotein

LOC

:   lateral occipital cortices

MMSE

:   Mini-Mental State Examination

MNI

:   Montreal Neurological Institute

MoCA

:   Montreal Cognitive Assessment

MP-RAGE

:   magnetization prepared by rapid-acquisition gradient-echo

PreCG

:   precentral gyrus

ROI

:   region of interest

T2DM

:   Type 2 diabetes mellitus

TMT

:   Trail Making Test

TSH

:   thyroid-stimulating hormone

VFT

:   Verbal Fluency Test.
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